John Tauro, DO
Neuromuscular Medicine · Norwich, CTNPI 1003915778
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,375 of the $53,731 with a category attached, or 62.1%. AbbVie accounts for 76.9% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2020 at $14,723 and has fallen 69.0% since, to $4,565 in 2025.
Across 951 payments — averaging $56.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$41K
- Pfizer$2K
- UCB, Inc.$846
- Teva Pharmaceuticals USA, Inc.$647
- Lundbeck LLC$621
- Amgen$585
- plus $8K from 54 others
What the payments were for
- Speaking & faculty fees$33,37562%
- Travel & lodging$1,8053%
- Food & beverage$18,52534%
- Education$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromuscular medicine providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvgartEfgartigimod Alfa-Fcab | 17 | $1,070,663 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 93 | $737,003 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 26 | $446,717 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 30 | $149,539 |
| BotoxOnabotulinumtoxina | 74 | $115,287 |
| MestinonPyridostigmine Bromide | 11 | $43,666 |
| Aimovig AutoinjectorErenumab-Aooe | 32 | $27,070 |
| QuliptaAtogepant | 13 | $26,901 |
| Nurtec OdtRimegepant Sulfate | 13 | $23,926 |
| UbrelvyUbrogepant | 17 | $16,107 |
| DepakoteDivalproex Sodium | 11 | $15,057 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 12 | $12,401 |
| Tegretol XrCarbamazepine | 18 | $8,409 |
| Gabapentin | 124 | $3,298 |
| Pyridostigmine Bromide | 36 | $3,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Argenx US, Inc.Vyvgart | $167 | $1,070,66317 claims |
| Grifols USA, LLCGamunex-C | $101 | $737,00393 claims |
| PfizerOctagam, Nurtec Odt | $1,627 | $470,64239 claims |
| AbbVieBotox, Qulipta, Ubrelvy | $41,305 | $158,295104 claims |
| CSL BehringPrivigen | $436 | $149,53930 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $116 | $3,13536 claims |
| Upsher-smith Laboratories LLCTopiramate | $42 | $11521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromuscular medicine providers in Connecticuton file to place this against a meaningful peer group, so we don't.
Other neuromuscular medicine in Norwich
- Sasa ZivkovicGuilford$37K
- Bhaskar RoyNew Haven$17K
- Barry GordonMeriden$3K
- Kevin FeliceNew Britain$2K
- David TinklepaughMystic$2K
- Ylec Cardenas CastilloNew Haven$1K
- Arpad FejosMiddletown$1K
- Bilal HameedNew London$1K
- Zara KhanWestport$1K
- Idaira Aguilar TejedorStratford$864
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.